| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |